Cholangiocarcinoma — evolving concepts and therapeutic strategies

Cited by (1,001)

Items 601–700 of 1,001

1. Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection
   EeeLN H. Buckarma, Gabriel De La Cruz, Mark Joseph Truty, David M. Nagorney, Sean Patrick Cleary, Michael L. Kendrick, Mitesh J. Borad, Rondell Patrell Graham, Gregory James Gores, Rory L. Smoot · 2022 · HPB
2. Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
   Paula Hoffmeister‐Wittmann, Andreas Möck, Federico Nichetti, Felix Korell, Christoph E. Heilig, Anna‐Lena Scherr, Michael Günther, Thomas Albrecht, Eblina Kelmendi, Kaiyu Xu et al. · 2022 · Liver International
3. RNA ‐sequencing reveals the expression profiles of tsRNAs and their potential carcinogenic role in cholangiocarcinoma
   Yanke Li, Lirong Yan, Ang Wang, Li‐yue Jiang, Qian Xu, Ben‐gang Wang · 2022 · Journal of Clinical Laboratory Analysis
4. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review
   Wei Zhang, Chu Luo, Zun-Yi Zhang, Bixiang Zhang, Xiaoping Chen · 2023 · Frontiers in Immunology
5. Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
   Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, Francesco Leonardi, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli · 2023 · Current Oncology
6. A novel benzamine lead compound of histone deacetylase inhibitor ZINC24469384 can suppresses HepG2 cells proliferation by upregulating NR1H4
   Qiuhang Song, Mingyue Li, Cong Fan, Yucui Liu, Lihua Zheng, Yongli Bao, Luguo Sun, Chunlei Yu, Zhenbo Song, Ying Sun et al. · 2019 · Scientific Reports
7. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis
   Zijun Gong, Jianwen Cheng, Pin-Ting Gao, Ao Huang, Yun‐Fan Sun, Kaiqian Zhou, Bo Hu, Shuang–Jian Qiu, Jian Zhou, Jia Fan et al. · 2019 · The Oncologist
8. Omega-3 polyunsaturated fatty acids suppress metastatic features of human cholangiocarcinoma cells by suppressing twist
   Chia-Ray Lin, Tsan-Mei Chu, Anin Luo, Shin-Jie Huang, Hsin‐Yiu Chou, Ming–Wei Lu, Jen‐Leih Wu · 2019 · The Journal of Nutritional Biochemistry
9. Endoscopic Perspective in Cholangiocarcinoma Diagnostic Process
   Ondřej Urban, Petr Vaněk, Vincent Zoundjiekpon, Přemysl Falt · 2019 · Gastroenterology Research and Practice
10. Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation
    Lining Huang, Xingming Jiang, Zhenglong Li, Jinglin Li, Xuan Lin, Zengtao Hu, Yunfu Cui · 2020 · Cancer Cell International
11. Impact of changes in the topographic classification of Klatskin tumor on incidence of intra‐ and extrahepatic bile duct cancer: A population‐based national cancer registry study
    Mee Joo Kang, Jiwon Lim, Sung‐Sik Han, Hyeong Min Park, Sun‐Whe Kim, Young‐Joo Won, Sang‐Jae Park · 2021 · Journal of Hepato-Biliary-Pancreatic Sciences
12. Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center
    Ana Lleò, Francesca Colapietro, Patrick Maisonneuve, Monia Aloise, Vincenzo Craviotto, Roberto Ceriani, Lorenza Rimassa, Salvatore Badalamenti, Matteo Donadon, Vittorio Pedicini et al. · 2021 · Cancers
13. Role of 3D quantitative tumor analysis for predicting overall survival after conventional chemoembolization of intrahepatic cholangiocarcinoma
    Irvin Rexha, Fabian M. Laage Gaupp, Julius Chapiro, Milena Anna Miszczuk, Johanna M. M. van Breugel, MingDe Lin, Menelaos Konstantinidis, Rafael Durán, Bernhard Gebauer, Christos S. Georgiades et al. · 2021 · Scientific Reports
14. Tumor Cell-Derived Extracellular Vesicles Promote the Growth, Metastasis and Chemoresistance in Cholangiocarcinoma by Delivering microRNA-210 to Downregulate RECK
    Yu Fu, Yahui Liu, Kai Liu, Ludong Tan · 2022 · Molecular Biotechnology
15. Surgical approaches for the treatment of perihilar cholangiocarcinoma
    Charles W. Kimbrough, Jordan M. Cloyd, Timothy Michael Pawlik · 2018 · Expert Review of Anticancer Therapy
16. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma
    Yong Dong Jiang, Xiaohu Zheng, Defeng Jiao, Peng Chen, Yechuan Xu, Haiming Wei, Yeben Qian · 2019 · EBioMedicine
17. Knowns and Unknowns: the Safety and Efficacy of Cancer Immunotherapy in Chronic Liver Disease
    David M. H. Chascsa, Jorge L. Rakela · 2018 · Current Hepatology Reports
18. Immunotherapy for hepatobiliary malignancies: Progress and prospective
    Lun–Xiu Qin · 2022 · Hepatobiliary & pancreatic diseases international
19. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis
    Charbel, Alphonse, Tavernar, Luca, Albrecht, Thomas, Brinkmann, Fritz, Verheij, Joanne, Roos, Eva, Vogel, Monika Nadja, Köhler, Bruno, Springfeld, Christoph, Brobeil, Alexander et al. · 2022 · British Journal of Cancer
20. Successful treatment of colorectal liver metastasis harboring intrahepatic cholangiocarcinoma
    Xiaofei Cheng, Feng Zhao, Dong Chen, Piao Yang, Weixiang Zhong, Xiangming Xu, Weilin Wang · 2018 · Medicine
21. Research trends of targeted therapy for cholangiocarcinoma from 2003 to 2022: a bibliometric and visual analysis
    Peng Huang, Feng Wen, Qiuji Wu, Pengfei Zhang, Qiu Li · 2023 · Clinical and Experimental Medicine
22. Global research trends on immunotherapy in cancer: A bibliometric analysis
    Zhichao Yao, Zhiyong Lin, Wu Weijia · 2023 · Human Vaccines & Immunotherapeutics
23. MRI-based automatic identification and segmentation of extrahepatic cholangiocarcinoma using deep learning network
    Chunmei Yang, Qin Zhou, Mingdong Li, Lulu Xu, Yanyan Zeng, Jiong Liu, Ying Wei, Feng Shi, Jing Chen, Pinxiong Li et al. · 2023 · BMC Cancer
24. Application of AI on cholangiocarcinoma
    Jianhao Huang, Xuesong Bai, Yanyu Qiu, Xiaodong He · 2024 · Frontiers in Oncology
25. Advances in research and application of photodynamic therapy in cholangiocarcinoma (Review)
    Yufeng Li, Yuhang Li, Yinghui Song, Sulai Liu · 2024 · Oncology Reports
26. Neurokinin‐1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS / JNK in intrahepatic cholangiocarcinoma
    Yang Yang, Xueyan Cao, Yuting Wang, Xinyu Wu, Ping Zhou, Lin Miao, Xueting Deng · 2024 · Liver International
27. A predictive radiotranscriptomics model based on DCE-MRI for tumor immune landscape and immunotherapy in cholangiocarcinoma
    Lu Chen, Guotao Yin, Ziyang Wang, Zifan Liu, Chunxiao Sui, Kun Chen, Tianqiang Song, Wengui Xu, Lisha Qi, Xiaofeng Li · 2024 · BioScience Trends
28. Extrachromosomal circular DNA (eccDNA) characteristics in the bile and plasma of advanced perihilar cholangiocarcinoma patients and the construction of an eccDNA-related gene prognosis model
    Shijie Fu, Yuyang Dai, Pengjun Zhang, Kanglian Zheng, Guang Cao, Liang Xu, Yujie Zhong, Chuanxin Niu, Xiaodong Wang · 2024 · Frontiers in Cell and Developmental Biology
29. ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma
    Fanghua Chen, Ke Gao, Yan Li, Yin Li, Yingcheng Charles Wu, Liangqing Dong, Zijian Yang, Jie-Yi Shi, Kun Guo, Qiang Gao et al. · 2024 · Molecular & Cellular Proteomics
30. Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US
    Kim R. Saverno, Kristin M. Zimmerman Savill, Cherrishe Brown‐Bickerstaff, Angele Kotomale, Michael J Rodriguez, Bruce A. Feinberg, Haobo Ren, Mike Blecker, Richard D. Kim · 2024 · The Oncologist
31. Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
    Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, Clemens Kreutz, Hannah Rasel, F. Bartsch, Hauke Lang, Kristina Endres · 2025 · Journal of Translational Medicine
32. Microbial Landscapes of the Gut–Biliary Axis: Implications for Benign and Malignant Biliary Tract Diseases
    David Meacci, Angelo Bruni, Alice Cocquio, Giuseppe Dell’Anna, Francesco Vito Mandarino, Giovanni Marasco, Paolo Cecinato, Giovanni Barbara, Rocco Maurizio Zagari · 2025 · Microorganisms
33. The morphology and application of stem cells in digestive system surgery
    Małgorzata Pucułek, Jacek Baj, Piero Portincasa, Monika Sitarz, Cezary Grochowski, Elżbieta Radzikowska · 2020 · Folia Morphologica
34. Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma
    Yu‐Chan Chang, Ming‐Huang Chen, Chun‐Nan Yeh, Michael Hsiao · 2020 · Biomolecules
35. Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
    Xing Huang, Tianyu Tang, Gang Zhang, Zhengtao Hong, Jian Xu, Dipesh Kumar Yadav, Xueli Bai, Tingbo Liang · 2020 · npj Precision Oncology
36. Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup
    Jian Zhao, Wei Zhang, Jun Zhang, Yun-Tian Chen, Wenjie Ma, Si-Yun Liu, Fu‐Yu Li, Bin Song · 2020 · Cancer Management and Research
37. A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery System
    Pier Francesco Ferrucci, Emilia Cocorocchio, Guido Bonomo, Gianluca Maria Varano, Paolo Della Vigna, Franco Orsi · 2021 · Cells
38. Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis
    Edoardo Maria Muttillo, Antonio Ciardi, Raffaele Troiano, Paolina Saullo, Gabriele Masselli, Marianna Guida, Alessandra Tortora, Isabella Sperduti, Giulio Marinello, Piero Chirletti et al. · 2021 · World Journal of Surgical Oncology
39. Development and validation of preoperative magnetic resonance imaging-based survival predictive nomograms for patients with perihilar cholangiocarcinoma after radical resection: A pilot study
    Jian Zhao, Wei Zhang, Chenglin Fan, Jun Zhang, Fang Yuan, Si-Yun Liu, Fu‐Yu Li, Bin Song · 2021 · European Journal of Radiology
40. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study
    Hannes Jansson, Pim B. Olthof, Annika M Bergquist, Marjolein A. P. Ligthart, Silvio Nadalin, Roberto Ivan TROISI, Bas Groot Koerkamp, Ruslan Alikhanov, Hauke Lang, Alfredo Guglielmi et al. · 2021 · HPB
41. The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
    Simon Johannes Gairing, Felix Thol, Lukáš Müller, Felix Hähn, Thomas Thomaidis, Carolin Czauderna, F. Bartsch, Michael Bernhard Pitton, Jens Uwe Marquardt, Marcus‐Alexander Wörns et al. · 2021 · Journal of Clinical Medicine
42. Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma
    Lynn E. Nooijen, Lotte C. Franken, Ali Belkouz, Ikrame Oulad Abdennabi, Marc G. Besselink, Olivier R. Busch, Rutger‐Jan Swijnenburg, Heinz‐Josef Klümpen, Joris I. Erdmann · 2021 · American Journal of Clinical Oncology
43. Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis
    Jiang, Qi, Huang, Jinsheng, Zhang, Bei, Li, Xujia, Chen, Xiuxing, Cui, Bokang, Li, Shengping, Guo, Guifang · 2022 · Frontiers in Immunology
44. Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma
    Yanhua Wu, Hayat Khizar, Yufei Hu, Jianfeng Yang · 2022 · Frontiers in Cell and Developmental Biology
45. The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients
    Matthew Parsons, Shane A. J. Lloyd, Skyler Bryce Johnson, Courtney L. Scaife, Heloisa Prado Soares, Rebecca Kim, Robin D. Kim, Ignacio Garrido‐Laguna, Randa Tao · 2022 · Journal of Gastrointestinal Cancer
46. Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment
    Yue Zhou, Lei Xu, Zhangding Wang, Hong‐Wen Liu, Xiang Zhang, Chuanjun Shu, Meng Zhang, Ting Wang, Xinyun Xu, Xiaohong Pu et al. · 2022 · Theranostics
47. Molecular Profile and Prognostic Value of BAP1 Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database Analysis
    Alessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, Alessandro Di Federico, Deniz Can Güven, Şuayib Yalçın, Giovanni Brandi · 2022 · Journal of Personalized Medicine
48. Noninvasive Cholangitis and Cholangiocarcinoma Screening Based on Serum Raman Spectroscopy and Support Vector Machine
    Na Su, Wubulitalifu Dawuti, Yan Hu, Hui Zhao · 2022 · Photodiagnosis and Photodynamic Therapy
49. Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma
    Liming Zhao, Anda Shi, Yan Yang, Zengli Liu, Xiaoqiang Hu, Lizhuang Shu, Yong‐chang Tang, Zongli Zhang · 2023 · Frontiers in Oncology
50. Tiliacora triandra Leaf Powder Ethanolic Extract in Combination with Cisplatin or Gemcitabine Synergistically Inhibits the Growth of Cholangiocarcinoma Cells In Vitro and in Nude Mouse Xenograft Models
    Arunta Samankul, Gulsiri Senawong, Suppawit Utaiwat, Jeerati Prompipak, Khanutsanan Woranam, Chanokbhorn Phaosiri, Banchob Sripa, Thanaset Senawong · 2023 · Medicina
51. Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome
    William A. Preston, Esther N Drill, Thomas Boerner, Rebecca Gelfer, James J. Harding, Eileen Mary O'Reilly, Andrea Cercek, Ghassan K. Abou‐Alfa, Wungki Park, Vinod P. Balachandran et al. · 2024 · JCO Precision Oncology
52. Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses
    Huayu Wu, Shuang Xia, Angui Liu, Minda Wei, Zhong‐Biao Chen, Yuxin Li, Yu He, Minjun Liao, Qiping Hu, Shang‐Ling Pan · 2019 · Molecular Medicine Reports
53. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.
    Xinyu Zhang, Pingting Gao, Xuan Yang, Jiabin Cai, Guangyu Ding, Xiao‐Dong Zhu, Yuan Ji, Guo‐Ming Shi, Ying‐Hao Shen, Jian Zhou et al. · 2018 · Europe PMC (PubMed Central)
54. Role of noncoding RNAs in cholangiocarcinoma (Review)
    Yinghao Lv, Zhenzhen Wang, Kun Zhao, Guokun Zhang, Shuai Huang, Yongfu Zhao · 2020 · International Journal of Oncology
55. Unsatisfactory Long-term Results of Liver Transplant in Patients With Intrahepatic Cholangiocarcinoma
    Maciej Krasnodębski, Michał Grąt, Maciej Jastrzębski, Michalina Szczęśniak, Marcin Morawski, Krzysztof Zając, Waldemar Patkowski, Krzysztof Zieniewicz · 2020 · Transplantation Proceedings
56. Surgical Approach to Recurrent Cholangiocarcinoma
    Hauke Lang · 2020 · Visceral Medicine
57. MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway
    Chaofeng Tang, Peng Yuan, Jian Wang, Yubo Zhang, Xiaowei Chang, Dong Jin, Lei Peng, Zhenhui Lu, Bendong Chen · 2021 · 3 Biotech
58. MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD88
    Yi Tang, Zhenyong Tang, Jianrong Yang, Tianqi Liu, Yuntian Tang · 2021 · Journal of Clinical and Translational Hepatology
59. Compelling Long-Term Results for Liver Resection in Early Cholangiocarcinoma
    Jan Bednarsch, Zoltán Czigány, Lara Rosaline Heij, Dong Liu, Marcel den Dulk, Georg J. Wiltberger, Philipp Bruners, Tom Florian Ulmer, Ulf P. Neumann, Sven Arke Lang · 2021 · Journal of Clinical Medicine
60. Potential mechanism of circRNA_000585 in cholangiocarcinoma
    Fengming Yi, Longxiang Xin, Long Feng · 2021 · Journal of International Medical Research
61. Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis
    Alice Laffusa, Antonio Ciaccio, Alessandra Elvevi, Camilla Gallo, Laura Ratti, Pietro Invernizzi, Sara Massironi · 2022 · European Journal of Gastroenterology & Hepatology
62. Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinoma
    Sean P. Martin, Justin A. Drake, Michael M. Wach, Samantha M. Ruff, Laurence P. Diggs, Jim Y. Wan, Meghan L. Good, Dana A. Dominguez, Reed I. Ayabe, Evan Scott Glazer et al. · 2019 · HPB
63. Diagnostic Value of Serum Biomarkers for Intrahepatic Cholangiocarcinoma
    Youdi Li, Yandi Huang, Jiu Chen · 2019 · Journal of College of Physicians And Surgeons Pakistan
64. Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review
    Dino Bekric, Daniel Neureiter, Markus Ritter, Martin Jakab, Martin Gaisberger, Martin Pichler, Tobias Kiesslich, Christian Mayr · 2020 · Journal of Clinical Medicine
65. Hesperidin delays cell cycle progression into the G0/G1 phase via suspension of MAPK signaling pathway in intrahepatic cholangiocarcinoma
    Jie Deng, Li Liu, Li Li, Jianhai Sun, Fei Yan · 2022 · Journal of Biochemical and Molecular Toxicology
66. Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models
    Surang Leelawat, Kawin Leelawat, Thunyatorn Yimsoo, Thaniya Wunnakup, Chaowalit Monton, Nanthaphong Khamthong, Fameera Madaka, Athip Maha, Thanapat Songsak · 2022 · Evidence-based Complementary and Alternative Medicine
67. TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p
    Corentin Louis, Tanguy Ferlier, Raffaële Leroux, Raphaël Pineau, Matthis Desoteux, Panagiotis Papoutsoglou, Delphine Leclerc, Gaëlle Angenard, Javier Vaquero, Rocı́o I.R. Macı́as et al. · 2023 · JHEP Reports
68. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
    Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda‐Heggemann, Thomas Baptist Brunner, Reiner Caspari, Enrico d. Toni, Frank Dombrowski, Matthias Evert et al. · 2024 · Zeitschrift für Gastroenterologie
69. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression
    Ziwei Liang, Yang Ge, Jianjian Li, Yunting Bai, Zeru Xiao, Rui Yan, Guangyu An, Donglei Zhang · 2024 · Journal of Cancer Research and Clinical Oncology
70. Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study
    Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Minrui He, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Li Xu, Yaojun Zhang et al. · 2024 · International Journal of Surgery
71. Potential of capsaicin as a combinatorial agent to overcome chemoresistance and to improve outcomes of cancer therapy
    Bethsebie Lalduhsaki Sailo, Anushka Garhwal, Anamika Mishra, Mangala Hegde, Ravichandran Vishwa, Sosmitha Girisa, Mohamed Abd Elhamid Abbas, Mohammed Saeed Alqahtani, Ayman Abdulhammed, Gautam Sethi et al. · 2025 · Biochemical Pharmacology
72. Advancing Precision Medicine: The Role of Genetic Testing and Sequencing Technologies in Identifying Biological Markers for Rare Cancers
    Joviana Farhat, Lara Alzyoud, Mohammad Alwahsh, Animesh Acharjee, Basem Al‐Omari · 2025 · Cancer Medicine
73. Advances in the endoscopic management of malignant biliary obstruction
    Thomas Thomaidis · 2020 · Annals of Gastroenterology
74. INTS8 is a therapeutic target for intrahepatic cholangiocarcinoma via the integration of bioinformatics analysis and experimental validation
    Qi Zhou, Ji Li, Xueying Shi, Dawei Deng, Fangyue Guo, Zhengpeng Wang, Wenhui Liu, Jinnan Zhang, Shilin Xia, Dong Shang · 2021 · Scientific Reports
75. Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis
    Woo Jin Choi, Tommy Ivanics, Marco P. A. W. Claasen, Steve Gallinger, Bettina E. Hansen, Gonzalo Sapisochín · 2022 · HPB
76. Establishment and verification of potential biomarkers for cholangiocarcinoma
    Shuai Wang, Leilei Yu, Xiangyu Sun, Bo Zhang · 2022 · Experimental and Therapeutic Medicine
77. RNF4 promotes tumorigenesis, therapy resistance of cholangiocarcinoma and affects cell cycle by regulating the ubiquitination degradation of p27kip1 in the nucleus
    Jie Huang, Wei Yang, Kainian Jiang, Yan Liu, Xiaolong Tan, Jian Luo · 2022 · Experimental Cell Research
78. Immunotherapy in Biliary Tract Cancers: Where Are We?
    Aparna Kalyan, Harshit Khosla, Richard D. Kim · 2022 · Current Oncology Reports
79. Pan-cancer analysis of DEPDC1 as a candidate prognostic biomarker and associated with immune infiltration
    Boquan Jia, Jun Liu, Xin Hu, Lu Xia, Ying Han · 2022 · Annals of Translational Medicine
80. Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence
    Vincenza Granata, Roberta Fusco, Federica De Muzio, Carmen Cutolo, Francesca Grassi, Maria Chiara Brunese, Igino Simonetti, Orlando Catalano, Michela Gabelloni, Silvia Pradella et al. · 2023 · Biology
81. Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis
    Guangxin Wang, Xia Gao, Zhi‐Jun Sun, Tianyou He, Chaogang Huang, Shouwei Li, Haocheng Long · 2023 · Anti-Cancer Drugs
82. Lenvatinib inhibits intrahepatic cholangiocarcinoma via Gadd45a-mediated cell cycle arrest
    Yan Xia, Dan Wang, Zhouyu Ning, Zhiqiang Meng · 2023 · Discover Oncology
83. Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma
    Xinjun Lu, Benjamin L. Green, Changqing Xie, Chao Liu, Xin Chen · 2023 · JHEP Reports
84. Small but mighty: How microRNAs drive the deadly progression of cholangiocarcinoma
    Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna Raad Al-Ameer, Luay Ali Khaleel, Sada Jasim Abdulameer, Ameer M. Hadi, Muna Salih Merza, Rahman Sahib Zabibah, Ahmed Yamany Ali · 2023 · Pathology - Research and Practice
85. Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma
    Junhua Wang, Yaoting Shi, Jianbo Chen, Juying Liu, Xiaotian Zhao, Jiaohui Pang, Ximin Sun, Yichen Tian, Qiuxiang Ou, Feng Xia et al. · 2023 · Cancer Biology & Therapy
86. Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinoma
    Liye Tao, Yali Wang, Zefeng Shen, Jingwei Cai, Junhao Zheng, Shunjie Xia, Zhongjie Lin, Zhe Wan, Haiou Qi, Renan Jin et al. · 2023 · Hepatology International
87. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases
    Ying Xü, Feng Ye, Lu Li, Yi Yang, Jingzhong Ouyang, Yanzhao Zhou, Sicong Wang, Lizhi Xie, Jinxue Zhou, Hong Zhao et al. · 2023 · Academic Radiology
88. Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
    Lenka N.C. Boyd, Lynn E. Nooijen, Mahsoem Ali, Jisce R. Puik, Jasmine Moustaquim, Stephanie M. Fraga Rodrigues, Robert Broos, Ali Belkouz, Laura L. Meijer, Tessa Y. S. Le Large et al. · 2023 · Frontiers in Pharmacology
89. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a systematic review of propensity score-matched studies
    Ya-Fei Hu, Hai‐Jie Hu, Wenjie Ma, Yanwen Jin, Fu‐Yu Li · 2023 · Updates in Surgery
90. Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma
    Abdullah Khalid Malik, Brian Ritchie Davidson, Derek Manas · 2024 · European Journal of Surgical Oncology
91. Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells
    Chutipa Chiawpanit, Methi Wathikthinnakon, Nunghathai Sawasdee, Nattaporn Phanthaphol, Jatuporn Sujjitjoon, Mutita Junking, Montarop Yamabhai, Jutatip Panaampon, Pa‐thai Yenchitsomanus, Aussara Panya · 2024 · International Immunopharmacology
92. Upregulated FFAR4 correlates with the epithelial-mesenchymal transition and an unfavorable prognosis in human cholangiocarcinoma
    Futao Meng, Mei Huang, Feng Shao, Qiang Huang · 2018 · Cancer Biomarkers
93. Oxaliplatin reverses the GLP‑1R‑mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling
    Bendong Chen, Wenyan Zhou, Wenchao Zhao, Peng Yuan, Chaofeng Tang, Genwang Wang, Junzhi Leng, Jinlong Ma, Xiaowen Wang, Yongfeng Hui et al. · 2019 · Oncology Letters
94. The role of extracellular vesicles in cholangiocarcinoma
    Mingzhen Bai, Wenkang Fu, Gang Su, Jie Cao, Long Gao, Chongfei Huang, Haidong Ma, Jinduo Zhang, Ping Yue, Bing Bai et al. · 2020 · Cancer Cell International
95. Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma
    Ziming Wang, Jiaming Lai, Lijian Liang, Xiaoyu Yin, Qian Wang, Quanyong Cheng, Chaoxu Zheng · 2020 · Translational Cancer Research
96. Preparation, characterization and primary evaluation of trilayered biliary stent films for anti-cholangiocarcinoma and anti-biofilm formation
    Liu Tian, Zhanjun Lu, Lei Lei, Ning Yang, Zhaoyang Chen, Beike Lu, Zhu Jin, Yuanyuan Shen, Shengrong Guo · 2021 · International Journal of Pharmaceutics
97. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis
    Hongbin Chang, Yixin Yao · 2022 · Bioengineered
98. Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma
    Ziyi Wang, Yaodong Zhang, Yananlan Chen, Shuochen Liu, Changxian Li, Xiangcheng Li · 2022 · Expert Review of Gastroenterology & Hepatology
99. Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
    Thanich Sangsuwannukul, Kamonlapat Supimon, Thaweesak Chieochansin, Kornkan Choomee, Jatuporn Sujjitjoon, Mutita Junking, Pa‐thai Yenchitsomanus · 2022 · PLoS ONE
100. Mechanisms and strategies to overcome immunotherapy resistance in hepatobiliary malignancies
     Jia Xiong, Qingqing Wang · 2022 · Hepatobiliary & pancreatic diseases international